Actively Recruiting
Control Interfaces for Operating Assistive Devices
Led by Centre Bouffard Vercelli - USSAP · Updated on 2025-07-10
30
Participants Needed
1
Research Sites
58 weeks
Total Duration
On this page
Sponsors
C
Centre Bouffard Vercelli - USSAP
Lead Sponsor
N
NEURINNOV
Collaborating Sponsor
AI-Summary
What this Trial Is About
Neurinnov, in collaboration with the CBV USSAP center and the CAMIN INRIA team, has conducted clinical investigations using various control interfaces, including EMG, IMU, contact sensors, and voice commands, to operate a motor neuroprosthesis. This neuroprosthesis is based on neural electrical stimulation, enabling the activation of multiples muscles via a single electrode. The clinical investigations have successfully demonstrated the feasibility of achieving grasping movements induced by neural electrical stimulation, which are controlled by the participant through external interfaces. These external interfaces were based on existing technologies but were only suitable for research purposes due to their lack of portability. The current investigation aims to validate fully portable interfaces designed by Neurinnov, which are intended to be integral components of a future medical device that includes an implanted stimulator and its neural electrodes. The study's goal is to demonstrate that these interfaces can be used by participants with sufficient success rate (clinical performance) to support daily use. Our main hypothesis is that the participants can effectively use at least two of the six control interfaces presented to them to detect their intention to perform a motor action within a software environment under constant conditions. These interfaces include voice commands, inertial measurement unit (IMU) sensors, surface electromyography (EMG) sensors, switch, joystick, and earswitch.
CONDITIONS
Official Title
Control Interfaces for Operating Assistive Devices
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Spinal cord injury defined by an AIS A, B or C score (complete or incomplete motor deficit below the lesion)
- Spinal cord injury at the neurological level above C7
- Age 18 to 80 years
- Neurological stability for more than 3 months with no changes in muscle testing
- Ability to follow instructions for testing and provide feedback on device use
- Signed informed consent after full information
- Affiliation with a social security system (excluding State Medical Aid)
You will not qualify if you...
- Deprivation of liberty by judicial or administrative decision
- Adults under legal protection or unable to provide informed consent
- Participation in another ongoing clinical trial
- Unstable psychiatric condition
- Severe cognitive impairment
- Unstable acute medical condition
- Insufficient proficiency in spoken and written French
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rehabilitation Center Bouffard-Vercelli USSAP
Perpignan, France, 66000
Actively Recruiting
Research Team
C
Charles FATTAL Charles FATTAL, MD, PhD
CONTACT
D
David GUIRAUD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here